Xcout Intel
GENEOS Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to GENEOS Therapeutics, Inc. among healthcare companies — ranked by similarity to what GENEOS Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see GENEOS Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About GENEOS Therapeutics, Inc.
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
GENEOS Therapeutics, Inc. at a glance
GENEOS Therapeutics, Inc. is a healthcare company headquartered in United States. Its most recent funding round, Series A3, raised $5M in September 2023. Xcout tracks 10 named people at GENEOS Therapeutics, Inc., including Greg Hamilton (President, Brightstar; CIO, Americo).
GENEOS Therapeutics, Inc. leadership
- Greg HamiltonPresident, Brightstar; CIO, Americo
- Dennis WalshCFO, Americo
- Casey CunninghamChief Scientific Officer, Santé Ventures
- Laurent HumeauChief Scientific Officer, Inovio Pharmaceuticals
- Niranjan Y. SardesaiFounder, President & CEO
- David B. WeinerW.W. Smith Endowed Chair in Cancer Research, The Wistar Institute
4 more named people on record for GENEOS Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
GENEOS Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A3 | $5M | 2 named | |
| SEC Form D filing | $17.2M | — | |
| SEC Form D filing | $10.4M | — | |
| SEC Form D filing | $4.5M | — | |
| Series A | $10.5M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 GENEOS Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to GENEOS Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
GEMMABio is a privately held therapeutics company founded in 2024 in Philadelphia, Pennsylvania, dedicated to developing novel gene therapies for rare diseases.
Similar healthcare company
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
Similar healthcare company
Infinitopes is a biotechnology research company based in Oxford, United Kingdom, focused on developing revolutionary off-the-shelf precision vaccines to prevent deaths from cancer metastases.
Similar healthcare company
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Biotechnology
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Biotechnology
Code Biotherapeutics, Inc. is a biotechnology company headquartered in the Greater Philadelphia area. The firm focuses on next-generation gene therapies and advanced medicine.
Biotechnology
Neogap Therapeutics is a privately held clinical-stage biopharmaceutical company founded in 2016 and located at the Cancer Center Karolinska in Stockholm, Sweden. The company focuses on immuno-oncology and is developing personalized therapies for cancer treatment.
Biotechnology
Red Ace Bio is a biotechnology company founded in 2023 to develop next-generation gene therapies targeting lasting cancer remission. The company is headquartered in State College, Pennsylvania.
Biotech
Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. Additionally, they are advancing hunTR, a platform focused on human neoantigen T-cell receptors, and mbIL-15, intended for solid tumor treatment. The company maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., a research and development partnership with The University of Texas MD Anderson Cancer Center, and both a patent licensing and R&D agreement with the National Cancer Institute. Previously known as ZIOPHARM Oncology, Inc., the company adopted its current name, Alaunos Therapeutics, Inc., in January 2022. Its headquarters are located in Houston, Texas.
Biotechnology
OncoSenX, Inc. is a late-stage preclinical biotechnology company headquartered in Seattle, Washington. The firm specializes in developing targeted cancer therapeutics and novel drug delivery pipelines. Its oncology technology works in coordination with parent company Entos's research platforms to advance precision gene therapies.
Biotechnology
Go Therapeutics, Inc. is a biopharmaceutical company applying advances in glycoproteomics to develop novel antibody-based cancer therapies and immuno-oncology treatments. Headquartered in Natick, Massachusetts, the company has been active since 2014.
Biotechnology
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of GENEOS Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for GENEOS Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →